How many syringe units is a KPV dose?

It depends on your water volume, which is why a fixed chart cannot answer it for every reader. Enter your vial size and water volume in the calculator for the unit mark, or read it off the reconstitution chart below if your combination is on it.

How much bacteriostatic water for a 10 mg KPV vial?

A microgram dose out of a milligram vial lands at a small unit mark, so more water usually helps: it spreads the dose across more units and makes a misread less costly. Change the water volume in the calculator and the unit mark and the whole chart update together.

Can KPV be taken orally instead of injected?

The engine catalog lists oral as an alternative route for KPV, and a substantial part of the literature concerns uptake through the intestinal peptide transporter PepT1, which is the mechanistic reason an oral route is discussed at all. The dose figures and the calculator on this page are for the subcutaneous route the dose table specifies.

Does the experience level change the dose?

Yes. It selects a different row in the engine dose table, changing the opening dose, standard dose, upper dose and ceiling. At the higher levels the dose table also allows splitting the daily amount across two administrations, which the frequency column shows verbatim.

Does body weight change the KPV dose?

No. The engine catalog does not flag KPV weight sensitive and the dose calculator applies no generic weight scaling, so the tool leaves the target alone. Peptides that do carry a per-kilogram factor get it applied; the rest do not, because inventing one would be worse than omitting it.

Does KPV need cycling?

The engine catalog carries an on-period and an off-period for it, both shown on this page and used by the supplies plan.

When is KPV not appropriate?

The conditions table on this page lists every health condition the engine's contraindication matrix associates with this compound, with the engine's own reason and the severity. A public page cannot know your health data, so it names what would change the answer.

Where do the numbers on this page come from?

The dose table, the ceilings and the frequency come from the Klarovel engine's own dose table, the same rows the protocol generator doses from. Route, timing, cycling and weight sensitivity come from the engine catalog. Nothing on this page is a number someone typed into an article, which is the failure mode most dosing pages share.

Is this calculator free?

Yes. No account, no paywall, no usage limit. The protocol engine behind it is a separate product, but the calculator is open.

Does Klarovel sell this peptide?

No. Klarovel is the protocol layer: a questionnaire, a deterministic rules engine and a generated protocol. Any product is fulfilled by partner suppliers, not by Klarovel.

Is this medical advice?

No. It is arithmetic over published dose data, presented as a reference. It is not a prescription and not a recommendation to use any compound. Discuss peptide use with a qualified clinician.

KPV dosage calculator

KPV is dosed in micrograms from a milligram vial, so the ratio between vial and dose is large and the syringe mark is small. Enter your vial size, water volume and experience level to get the exact mark.

Below the calculator: a full reconstitution chart, the dose envelope per experience level, the cycle length, a supplies plan, the health conditions that change the answer, and the references. Every dose figure is read from the Klarovel engine's dose table, never typed into the page.

How many milligrams are in your KPV (Lys-Pro-Val) vial?

How much bacteriostatic water are you adding?

Syringe size

Experience with injectable peptides

Selects the dose row the engine would use, which changes the target, the upper bound and the ceiling together.

Body weight

The engine catalog does not flag KPV (Lys-Pro-Val) weight sensitive, and the dose calculator applies no generic weight scaling, so this does not change the target. Inventing a per-kilogram rule would be worse than leaving it alone.

Age 65 or over

Standard dose at the beginner level

6.0 units

300 mcg

Concentration: 5 mg/ml
Injection volume: 0.06 ml
Doses per vial: 33

Frequency for this level: once daily. Timing: Any time. Route: subcutaneous.

Phase by phase, at your mix

The three phases in the order the engine escalates a dose, with the unit mark for each at 10 mg in 2 ml. Change the experience level, weight or age above and the whole table recomputes.

Dose and syringe units per titration phase
Phase	Dose	Draw	Doses per vial
Phase 1, opening dose	250 mcg	5.0 units	40
Phase 2, standard dose	300 mcg	6.0 units	33
Phase 3, upper dose	400 mcg	8.0 units	25
Ceiling, not exceeded	500 mcg	10.0 units	20

Doses read from the beginner row of dose_protocols, the engine's dose table. Unit marks are arithmetic over your vial size and water volume.

KPV (Lys-Pro-Val) dose envelope by experience level

Every level side by side, unmodified. This is the raw dose table, so the shape of the ramp is visible instead of collapsed into a single recommended number.

Dose envelope per experience level
Experience	Opening	Standard	Upper	Ceiling	Frequency
Never used peptides	200 mcg	200 mcg	250 mcg	500 mcg	once daily
Researched, not used	200 mcg	250 mcg	300 mcg	500 mcg	once daily
Beginner	250 mcg	300 mcg	400 mcg	500 mcg	once daily
Intermediate	300 mcg	400 mcg	500 mcg	500 mcg	once daily or split into twice daily
Experienced	300 mcg	500 mcg	500 mcg	500 mcg	once daily or split into twice daily

Every cell read verbatim from dose_protocols. Where a level repeats the same figure across columns, that is what the table holds: no ramp has been invented to fill the row.

KPV (Lys-Pro-Val) reconstitution chart

Pre-calculated syringe units for every water volume against the dose figures this compound actually uses, at your selected vial size of 10 mg. A cell reading "n/a" means the draw exceeds a 100-unit syringe at that concentration.

Syringe units per water volume for each sourced dose figure
BAC water	Conc.	Opening250 mcg	Standard300 mcg	Upper400 mcg	Ceiling500 mcg
1 ml	10 mg/ml	2.5	3	4	5
1.5 ml	6.67 mg/ml	3.8	4.5	6	7.5
2 ml	5 mg/ml	5	6	8	10
2.5 ml	4 mg/ml	6.3	7.5	10	12.5
3 ml	3.33 mg/ml	7.5	9	12	15
4 ml	2.5 mg/ml	10	12	16	20
5 ml	2 mg/ml	12.5	15	20	25

Column doses are the beginner row's opening, standard, upper and ceiling figures from dose_protocols. Unit marks are arithmetic.

Supplies for one cycle

One on-cycle runs 8 weeks followed by 4 weeks off, from the engine catalog. Multiplied out at the standard dose and your mix, that is what the cycle costs in consumables.

Bacteriostatic water bottle size

Supplies for one on-cycle
Cycle length	8 weeks on, 4 weeks off
Administrations per week	7
Total administrations	56
Vials of 10 mg	2
Insulin syringes	56 (30-unit holds the draw)
Bacteriostatic water	4 ml, 1 bottle of 10 ml

Cycle length, loading phase and taper from PEPTIDE_CATALOG. Administrations per week derived from the frequency string on the dose row. Counts are arithmetic.

Save your reconstitution. Get the protocol it belongs in.

Free founding-member access while spots last. We'll send your reconstitution + a link to claim your slot.

About KPV (Lys-Pro-Val)

KPV is a tripeptide of lysine, proline and valine, the C-terminal fragment of alpha-melanocyte-stimulating hormone. Work on alpha-MSH established the anti-inflammatory activity, and later work localised much of it to this three-residue tail.

A notable strand of the literature concerns uptake through PepT1, the intestinal peptide transporter, which is why KPV appears in gut-inflammation contexts and why an oral route is discussed alongside injection. The engine catalog carries oral as an alternative route for it.

The dose sits in micrograms while the vial is labelled in milligrams, a thousandfold gap. The calculator works in the unit the engine dose table declares and never infers a unit from the magnitude of a number.

Administration and cycling

Administration and cycling reference
Route	subcutaneous
Timing	Any time
Catalog frequency	once daily
Cycle	8 weeks on, 4 weeks off
Taper before the off period	Not specified
Loading phase	None
Weight sensitive	No

Catalog note: Inject subcutaneously or take orally for gut inflammation. Derived from alpha-MSH. Strong anti-inflammatory properties.

Every row above is read from PEPTIDE_CATALOG, the engine catalog, and the note is quoted verbatim rather than paraphrased.

When this would not be recommended for you

A public page cannot know your health data, so it cannot tell you whether a compound is appropriate. What it can do is list the conditions the engine's contraindication matrix associates with this compound, and what the engine does about each. In a generated protocol these resolve automatically and the reason is shown alongside the exclusion.

Health conditions and the engine's action
Condition	Engine action	Reason
Autoimmune	Caution	Immunomodulatory peptides may worsen autoimmune conditions. Discuss with rheumatologist/immunologist before use.

Conditions, severities and reasons read verbatim from CONTRAINDICATION_RULES, the engine's contraindication matrix. This is not the full set of things worth raising with a clinician; it is the set the engine acts on.

Questions

How many syringe units is a KPV dose?: It depends on your water volume, which is why a fixed chart cannot answer it for every reader. Enter your vial size and water volume in the calculator for the unit mark, or read it off the reconstitution chart below if your combination is on it.
How much bacteriostatic water for a 10 mg KPV vial?: A microgram dose out of a milligram vial lands at a small unit mark, so more water usually helps: it spreads the dose across more units and makes a misread less costly. Change the water volume in the calculator and the unit mark and the whole chart update together.
Can KPV be taken orally instead of injected?: The engine catalog lists oral as an alternative route for KPV, and a substantial part of the literature concerns uptake through the intestinal peptide transporter PepT1, which is the mechanistic reason an oral route is discussed at all. The dose figures and the calculator on this page are for the subcutaneous route the dose table specifies.
Does the experience level change the dose?: Yes. It selects a different row in the engine dose table, changing the opening dose, standard dose, upper dose and ceiling. At the higher levels the dose table also allows splitting the daily amount across two administrations, which the frequency column shows verbatim.
Does body weight change the KPV dose?: No. The engine catalog does not flag KPV weight sensitive and the dose calculator applies no generic weight scaling, so the tool leaves the target alone. Peptides that do carry a per-kilogram factor get it applied; the rest do not, because inventing one would be worse than omitting it.
Does KPV need cycling?: The engine catalog carries an on-period and an off-period for it, both shown on this page and used by the supplies plan.
When is KPV not appropriate?: The conditions table on this page lists every health condition the engine's contraindication matrix associates with this compound, with the engine's own reason and the severity. A public page cannot know your health data, so it names what would change the answer.
Where do the numbers on this page come from?: The dose table, the ceilings and the frequency come from the Klarovel engine's own dose table, the same rows the protocol generator doses from. Route, timing, cycling and weight sensitivity come from the engine catalog. Nothing on this page is a number someone typed into an article, which is the failure mode most dosing pages share.
Is this calculator free?: Yes. No account, no paywall, no usage limit. The protocol engine behind it is a separate product, but the calculator is open.
Does Klarovel sell this peptide?: No. Klarovel is the protocol layer: a questionnaire, a deterministic rules engine and a generated protocol. Any product is fulfilled by partner suppliers, not by Klarovel.
Is this medical advice?: No. It is arithmetic over published dose data, presented as a reference. It is not a prescription and not a recommendation to use any compound. Discuss peptide use with a qualified clinician.

Other peptide calculators

References

These papers cover KPV and its parent peptide alpha-MSH: anti-inflammatory mechanism, PepT1-mediated uptake, delivery routes and stability.

The dose figures on this page are not sourced from these papers. They are read from the Klarovel engine's own dose table, which is cited inline wherever a number appears. These references cover mechanism, pharmacology and clinical context.

18 references, every identifier resolved against NCBI on 2026-07-30. Per peptide, a relevance-sorted esearch was run and every returned id was resolved through esummary. Any id esummary could not resolve was dropped, and any record carrying the 'Retracted Publication' pubtype was dropped. Titles, journals, years and first authors below are the values esummary returned, not authored text. One retracted record was dropped: PMID 37696839 (thymosin beta 4 query).

1.Dalmasso G et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology 2008. PMID 18061177 PMC2431115
2.Kannengiesser K et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis 2008. PMID 18092346
3.Getting SJ et al. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther 2003. PMID 12750433
4.Elliott RJ et al. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol 2004. PMID 15102092
5.Luger TA et al. New insights into the functions of alpha-MSH and related peptides in the immune system. Ann N Y Acad Sci 2003. PMID 12851308
6.Ichiyama T et al. The neuroimmunomodulatory peptide alpha-MSH. Ann N Y Acad Sci 2000. PMID 11268347
7.Catania A et al. The neuropeptide alpha-MSH in host defense. Ann N Y Acad Sci 2000. PMID 11268348
8.Cutuli M et al. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol 2000. PMID 10670585
9.Xiao B et al. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Mol Ther 2017. PMID 28143741 PMC5498804
10.Viennois E et al. Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cell Mol Gastroenterol Hepatol 2016. PMID 27458604 PMC4957955
11.Pawar KR et al. Stability-indicating HPLC assay for lysine-proline-valine (KPV) in aqueous solutions and skin homogenates. Biomed Chromatogr 2015. PMID 25298219
12.Pawar K et al. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. J Pharm Sci 2017. PMID 28343991
13.Shao W et al. In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis. Biomater Sci 2021. PMID 34846053
14.Land SC et al. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol 2012. PMID 22837805 PMC3403564
15.Bonfiglio V et al. Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide. Exp Eye Res 2006. PMID 16965771
16.Brzoska T et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 2008. PMID 18612139
17.Gravina AG et al. The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials. Cells 2023. PMID 37508552 PMC10378568
18.Sung J et al. Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway. Tissue Cell 2025. PMID 40073467

Beyond the arithmetic

Your health data, your protocol.

A calculator converts a dose into syringe units. The Klarovel engine decides the dose: it reads your health data, resolves contraindications, sets the envelope by experience level, removes incompatible pairs and builds the cycling and monitoring schedule. Blood work is optional and sharpens the result. It is never required.